Cargando…
One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome
PURPOSE: During a follow-up program of patients admitted for COVID-19 at our non-ICU Unit, we found that 37% of them had decreased diffusing lung capacity for carbon monoxide (DLCO) 3–6 months after discharge. This prospective observational study aimed to evaluate the evolution of changes in DLCO an...
Autores principales: | Fortini, Alberto, Rosso, Aurelio, Cecchini, Paolo, Torrigiani, Arianna, Lo Forte, Aldo, Carrai, Paolo, Alessi, Chiara, Fabbrizzi, Francesca, Lovicu, Elena, Sbaragli, Serena, Faraone, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777423/ https://www.ncbi.nlm.nih.gov/pubmed/35061232 http://dx.doi.org/10.1007/s15010-022-01755-5 |
Ejemplares similares
-
COVID-19: persistence of symptoms and lung alterations after 3–6 months from hospital discharge
por: Fortini, Alberto, et al.
Publicado: (2021) -
Effectiveness and safety of noninvasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure: a single center, non-ICU setting experience
por: Faraone, Antonio, et al.
Publicado: (2020) -
Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection
por: Byanova, Katerina L., et al.
Publicado: (2023) -
Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
por: Sivova, Nadia, et al.
Publicado: (2013) -
The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension
por: Stadler, Stefan, et al.
Publicado: (2019)